Skip to main content
SpringerLink
Log in

Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample

  • Original Article
  • Published:
Acta Diabetologica Aims and scope Submit manuscript

Abstract

The metabolic syndrome (MS) leads to serious health problems like diabetes and has serious economic consequences for multinational companies. Thus, the workplace is an important setting for primary prevention. Aim of this study was to evaluate the prevalence of MS in a mixed working population to provide a basis for interventional strategies. In 2006, 1,594 employees attended a screening program at BASF Ludwigshafen, the number of employees with MS was determined and the distribution of impaired glucose tolerance (IGT), type 2 diabetes and cardiovascular disease (CVD) analyzed. The study-population consisted of 1,075 men and 519 women, aged 17–64. 374 individuals (23.5%) were classified to be affected by MS, of which 86.9% were male (prevalence MS in men 30%, in women 9.7%). Subjects with MS had higher BMI (P < 0.01), blood pressure (P < 0.01), heart rate (P < 0.01), liver enzymes (P < 0.01), uric acid (P < 0.01) and LDL (P < 0.01), while HDL was significantly lower (P < 0.01). (Pre)-Diabetes and CVD were found more frequently in subjects with MS. There were no significant differences between individuals with different types of employment (“white collar vs. blue collar” workers) or smoking status. We found a high prevalence of MS in our working population, thus interventional programmes should be implemented. The workplace-setting can be used to promote long-term prevention strategies in this adult working population.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Eckel RH, Grundy SM, Zimmet PZ (2005) The metabolic syndrome. Lancet 365:1414–1428

    Article  Google Scholar 

  2. Cameron AJ, Shaw JE, Zimmet PZ (2004) The metabolic syndrome: prevalence in worldwide populations. Endocrinol Metabo Clin N Am 33:351–376

    Article  Google Scholar 

  3. Isomaa B, Almgren P (2001) Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care 24(4):683–689

    Article  PubMed  CAS  Google Scholar 

  4. Hertz RP, Unger AN (2004) The impact of obesity on work limitations and cardiovascular risk factors in the US workforce. J Occup Environ Med 46(12):1196–1203

    PubMed  Google Scholar 

  5. International diabetes federation (2005) The IDF consensus worldwide definition of the metabolic syndrome. Brussels: IDF. Available at: http://www.idf.org/webdata/docs/IDF_Metasyndrome_definition.pdf (accessed May 2005)

  6. Alberti KG, Zimmet P, Shaw J (2005) IDF Epidemiology task force consensus group. The metabolic syndrome–a new worldwide definition Lancet 24–30;366(9491):1059–1062

  7. Working toward wellness—World Economic Forum (2006) Extracted and calculated from http://laborsta.ilo.org/cgi-bin/brokerv8.exe#468 on 11 December 2006

  8. Lindström J, Tuomilehto J (2003) The diabetes risk score—a practical tool to predict type 2 diabetes risk. Diabetes Care 26:725–731

    Article  PubMed  Google Scholar 

  9. Expert committee on the diagnosis and classification of diabetes mellitus. follow-up report on the diagnosis of diabetes mellitus (2003) Diabetes Care 26(11):3160–3167

    Google Scholar 

  10. National Center for chronic disease prevention and health promotion—national diabetes fact sheet: http://www.cdc.gov/diabetes/pubs/general.htm

  11. Park YW, Zhu S, Palaniappan L, Heshka S, Carnethon MR, Heymsfield SB (2003) The metabolic syndrome: Prevalence associated risk factor findings in the US population from the third national health and nutrition survey, 1998–1994. Arch Intern Med 163:427–436

    Article  PubMed  Google Scholar 

  12. Godefroi R, Klementowitcz P (2005) Metabolic syndrome in a screened worksite sample: prevalence and predictors. Cardiology 103(3):131–136

    Article  PubMed  Google Scholar 

  13. Gesundheitsberichterstattung des Bundes „Gesundheit in Deutschland”: (Online Artikel)—Aufgerufen am 06.12.2006 http://www.rki.de/cln_011/nn_1001054/DE/Content/GBE/Gesundheitsberichterstattung/GesInDtld/gesundheitsbericht,templateId=raw,property=publicationFile.pdf/gesundheitsbericht

  14. Sabinsky MS, Toft U, Raben A, Holm L (2006) Overweight men’s motivations and perceived barriers towards weight loss. Eur J Clin Nutrit 61(4):526–531

    Google Scholar 

  15. Zober A, Schilling D, Ott MG, Schauwecker P, Riemann JF, Messerer P (1998) Helicobacter pylori infection: PREVALENCE, clinical relevance in a large company. J Occup Environ Med 40:586–594

    Article  PubMed  CAS  Google Scholar 

  16. Webendorfer S, Messerer P, Eberle F, Zober A (2004) Precautions for intestinal cancer in the workplace. An initiative for secondary prevention in the BASF joint-stock company. Dtsch Med Wochenschr 129:239–243

    Article  PubMed  CAS  Google Scholar 

  17. Buck H, Kistler E, Mendius HG: Demographic change in the World of Work (2002) Bundesministerium für Bildung und Forschung. Stuttgart. ISBM:3-8167-5180-1

  18. Metabolic syndrome and employer sponsored medical benefits: an actuarial analysis—http://www.dfwbgh.org/events06/Milliman%20Report.pdf

Download references

Author information

Authors and Affiliations

  1. Occupational Medical and Health Protection Department, BASF Aktiengesellschaft, 67056, Ludwigshafen, Germany

    Christoph Oberlinner & Andreas Zober

  2. Department of Internal Medicine, Endocrinology, Metabolism and Clinical Chemistry, University of Heidelberg, INF 410, 69129, Heidelberg, Germany

    Per M. Humpert, Peter P. Nawroth & Michael Morcos

Authors
  1. Christoph Oberlinner
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Per M. Humpert
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Peter P. Nawroth
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Andreas Zober
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Michael Morcos
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Christoph Oberlinner.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Oberlinner, C., Humpert, P.M., Nawroth, P.P. et al. Metabolic syndrome in a large chemical company: prevalence in a screened worksite sample. Acta Diabetol 45, 31–35 (2008). https://doi.org/10.1007/s00592-007-0015-6

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00592-007-0015-6

Keywords

Search

Navigation